Jefferson Institute for Bioprocessing

The Jefferson Institute for Bioprocessing (JIB) serves as a CDMO-plus partner for process development, product development, and customized training and workforce development, offering a fully flexible single-use facility with BSL1 and BSL2 bioprocessing capabilities. Its team supports preclinical process development and offers bioprocessing expertise across major large-molecule therapeutic modalities, with new cGMP capabilities launching to support cell and gene therapy programs from preclinical through Phase I/II manufacturing.